Facebook
Instagram
Pinterest
Reddit
Tumblr
X
Youtube
Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 167
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Pα+ Psychedelic Bulletin #227: A Closer Look at Compass’ 6-Month Data; AtaiBeckley Deal Update; ‘Rysanso’ Brand MDMA?
Compass Closes Out Phase 3 With 6-Month COMP006 Data, Eyes H1’27 Launch
Psychedelic Policy Briefing: Week of July 6, 2026
Psychedelics Today at the Aspen Psychedelic Symposium
The Framework Gap in Psychedelic Practice: An Introduction to the 8-Circuit Model of Consciousness
Psychedelic Bulletin #116 – Ketamine Combo Co. Scores $10m; DEA Drops...
MindMed Completes 1-for-15 Reverse Share Split
PT350 – Jim Gilligan – Psilocybin and Accessing the “Off” Switch...
MindMed Announces First Patient Dosed in Phase 2b Trial of MM-120...
Optimi Health Announces Canadian Retail and E-Commerce Distribution Agreements for Functional...
MindMed Announces First Patient Dosed in Phase 2b Trial of MM-120...
FILAMENT HEALTH APPOINTS NEW MEMBERS TO BOARD OF DIRECTORS AND ADVISORY...
BetterLife Lead Drug (BETR-001) Promotes Structural Neural Plasticity with Possible Nootropic...
Clearmind Medicine Announces Additional Positive Pre-Clinical Results for its Cocaine Addiction...
Algernon Pharmaceuticals’ Largest Shareholder AlphaNorth Asset Management Increases Ownership Position
Load more